Among them, the biggest benefit is the biomedical industry. It is necessary to set up a M&A fund with a scale of 10 billion, which is specifically aimed at the merger and reorganization of the biomedical industry! The focus is on local enterprises in Shanghai, especially the biomedicine of listed companies in Shanghai.Wentai Technology: Shareholders plan to reduce their holdings by no more than 2%;Xinhua News Agency: China's monetary policy has changed from "prudent" to "moderately loose" to send a positive signal.
China Research Institute: Wang Xiuyun reduced its shareholding by 1%. At present, the company has not directly involved in the application field of humanoid robots.First, heavy! Shanghai merger and reorganization action plan announcedTrue Vision: The controlling shareholder and others intend to reduce their holdings by 4% in total;
In short, it is the recent big bull stocks that have been announced to reduce their holdings. For example, Yiming Food has 11 consecutive boards, and the price of the world has reached a record high. Zhongyan shares have two 20cm daily limit! They are all popular topics such as AI applications and robots. Many have indeed risen a lot, even to record highs, but the reason is to rub a hot spot. In this case, it is normal for shareholders to reduce their holdings! The human heart is like this, and you can't stop it.Recently, all localities are vigorously promoting mergers and acquisitions, first in Shenzhen and then in Shanghai, and it is estimated that Beijing will soon. The listed companies in the north and Shenzhen are all active, and the merger of Shanghai benchmark brokerage Haitong+Guotai Junan has landed! Other places will follow suit, but mergers and acquisitions are really difficult to grasp, and it is estimated that there are more local+state-owned assets.Second, Contemporary Amperex Technology Co., Limited's enlargement trick: special dividends for factories in Europe
Strategy guide
12-13
Strategy guide 12-13
Strategy guide 12-13
Strategy guide
12-13
Strategy guide 12-13
Strategy guide
Strategy guide 12-13
Strategy guide